Contineum Therapeutics, Inc. (CTNM) stock

CTNMNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/30

$9.86+0.08 (+0.82%)

Close on Nov 13, 2026Market cap $370.94MP/E –Yield –

Contineum Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

Contineum Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?